论文部分内容阅读
目的比较不同给药方法对糖尿病合并与伴发心力衰竭疗效的影响。方法将74例糖尿病患者分为胰岛素泵持续皮下输注门冬胰岛素(CSII)组(静脉输注5%葡萄糖者,每4g葡萄糖增加基础量胰岛素1U)及多次皮下注射胰岛素(MSII)组4次/d。结果两组治疗24h平均血糖值、疗效、治疗后B型尿钠肽(BNP)及LVEF、低血糖事件发生率比较差异有统计学意义(P≤0.01)。结论 CSII治疗糖尿病合并与伴发心力衰竭疗效优于MSII。
Objective To compare the effects of different administration methods on the efficacy of diabetes mellitus and concomitant heart failure. Methods Seventy-four patients with diabetes mellitus were divided into three groups: insulin pump, subcutaneous insulin aspart insulin (CSII) group (intravenous infusion of 5% glucose, 1U insulin per 4g glucose) and subcutaneous injection of insulin (MSII) Times / d. Results 24h mean blood glucose treatment, curative effect, B-type natriuretic peptide (BNP) and LVEF, the incidence of hypoglycemic events was significantly different (P≤0.01). Conclusion CSII is superior to MSII in the treatment of diabetes mellitus and concomitant heart failure.